Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2025 09:15 ET | Source: Research and Markets

Acute Bacterial Skin and Skin Structure Infection Market Analysis Report 2025-2035: Pipeline Advancements, Rising R&D Investment, and New Drug Approvals Poised to Accelerate Growth

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Acute Bacterial Skin and Skin Structure Infection Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast,...
October 22, 2025 04:00 ET | Source: smartbax GmbH

smartbax announces a €4.7 M Pre-Series A round to advance novel antibiotic compound through preclinical stage

Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a platform of small-molecule enzymatic activators that induce self-digestion...
October 15, 2025 04:00 ET | Source: AKAMPION

Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund

-- Existing and new investors joining forces to support the accelerated development of Omnix´s novel, first-in-class antimicrobials pipeline -- Funding underlines urgent global need for novel,...
June 25, 2025 07:22 ET | Source: Perdue Farms

NEW STUDY IDENTIFIES ADDITIONAL LINKS BETWEEN POULTRY ANTIBIOTIC USE AND HUMAN DRUG RESISTANCE

Salisbury, MD, June 25, 2025 (GLOBE NEWSWIRE) -- A new study, published in mSphere, a journal of the American Society for Microbiology, suggests some antibiotics used in conventional poultry farming...
April 11, 2025 03:00 ET | Source: inbiome

Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals

www.inbiome.com Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID...
January 23, 2025 07:30 ET | Source: FACT.MR

Clostridium Difficile Infection Treatment Market Size Worth US$ 2.28 Billion by 2034 at a CAGR Of 6.3% | Fact.MR Report

Rockville, MD, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The global Clostridium difficile infection treatment market has been estimated at US$ 1.24 billion for 2024 and is projected to expand at a CAGR of...
December 26, 2024 04:45 ET | Source: Research and Markets

Antibiotic Resistance Therapeutics Market Research Report 2025-2029 - Search for Alternatives to Antibiotics Creates New Global Goldrush

Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Therapeutics Market 2025-2029 - Insights by Pathogen and Therapy Type, with Situation Analysis, Executive, and Investor Guides"...
October 15, 2024 10:31 ET | Source: Research and Markets

Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies

Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
September 26, 2024 04:03 ET | Source: inbiome

Inbiome Receives FDA Breakthrough Device Designation for Revolutionary Molecular Culture ID Technology, Transforming Bacterial Diagnostics

www.inbiome.com More precise diagnostics lead to quicker, more accurate patient treatment, saving lives and improving patient outcomesUS market introduction foreseen early 2026 ...
September 02, 2024 05:59 ET | Source: Research and Markets

Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%

Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Impetigo Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Impetigo Drugs was...